Equities

Hyuga Primary Care Co Ltd

7133:TYO

Hyuga Primary Care Co Ltd

Actions
  • Price (JPY)1,182.00
  • Today's Change17.00 / 1.46%
  • Shares traded2.70k
  • 1 Year change-46.13%
  • Beta--
Data delayed at least 20 minutes, as of Nov 06 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hyuga Primary Care Co Ltd is a Japan-based company mainly engaged in the provision of home-visit pharmacy services, discharge support services and care plan services for home-based patients. The Company operates through four business segments. The Home-visit Pharmacy segment is engaged in the delivery of medicines to outpatients and home-based patients based on prescriptions issued by medical institutions. The Kirari Prime segment is engaged in the provision of know-how and information systems to collaborative pharmacies. The Care Plan segment is engaged in the provision of care planning services, as well as contact and coordinate services with each service offices. The Taisapo segment is engaged in the provision of discharged patient introduction services for nursing care facilities. The Company is also engaged in the development and sale of wearable devices for long-term care facilities, and other information and communication technology (ICT) business.

  • Revenue in JPY (TTM)8.73bn
  • Net income in JPY499.36m
  • Incorporated2007
  • Employees544.00
  • Location
    Hyuga Primary Care Co Ltd2-2-1, Kasugabarukita-machiKASUGA-SHI 816-0802JapanJPN
  • Phone+81 925582120
  • Fax+81 925582121
  • Websitehttps://www.hyuga-primary.care/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7133:TYO since
announced
Transaction
value
Medical MindAnnounced27 Dec 202327 Dec 2023Announced-33.56%3.51m
Data delayed at least 20 minutes, as of Nov 06 2024 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sophia Holdings Co Ltd8.88bn-9.61m5.06bn193.00--1.4913.060.57-6.53-6.532,548.55725.471.2110.487.5446,003,140.00-0.13072.93-0.21035.0937.6835.07-0.10822.321.5711.170.40460.00-4.1414.77-577.93---12.58--
Hyuga Primary Care Co Ltd8.73bn499.36m8.44bn544.0017.314.7611.760.967167.2967.291,176.42244.811.7929.436.4116,050,780.0010.25--16.41--22.98--5.72--1.0759.520.6145--24.46--15.19------
Healthlead PCL8.13bn344.26m9.89bn484.0028.732.2915.451.220.28020.28026.623.521.335.22147.76--5.649.006.6011.2423.1322.774.235.462.4522.960.2145--7.64---36.84------
Satudora Holdings Co Ltd96.62bn481.00m11.16bn1.11k22.531.196.100.115534.8034.806,987.78656.462.156.8133.4887,282,740.001.100.7972.201.4924.8424.390.51330.36310.463112.170.628742.259.192.45440.2374.56-5.881.39
Medical System Network Co Ltd117.12bn1.88bn12.53bn3.74k6.530.78772.450.10762.6662.663,926.12519.251.7311.0835.1231,283,120.002.802.194.303.3541.6440.831.621.330.570315.090.606423.755.303.2715.5332.12-7.853.71
Dingdang Health Technology Group Ltd104.16bn-4.22bn15.18bn2.51k--0.3654--0.1457-0.1627-0.16274.021.591.575.6143.272,041,874.00-6.53-55.91-9.42-82.5132.3832.74-4.17-35.831.86--0.0766--12.1952.7292.03--13.40--
Sunshine Holdings PLC29.18bn2.32bn17.31bn1.70k7.451.804.880.59319.139.13114.6537.821.333.455.0433,119,650.0014.0512.8727.3423.7430.8729.6910.5810.291.0120.220.27416.937.0319.6597.4947.20-5.6948.41
Charmacy Pharmaceutical Co Ltd95.71bn1.10bn18.96bn834.0017.161.5010.940.19810.52450.524545.436.001.475.494.765,904,141.001.701.798.487.996.916.161.151.240.77142.440.588237.095.472.27-43.252.48-16.010.0027
Kimia Farma Tbk PT97.46bn-16.48bn34.33bn10.71k--0.6683--0.3523-307.59-311.081,817.52957.720.54152.784.36882,472,800.00-11.90-1.82-23.42-3.2224.0535.14-21.98-3.080.4154-3.760.5702--7.933.33-737.71---9.87--
Data as of Nov 06 2024. Currency figures normalised to Hyuga Primary Care Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.92%Per cent of shares held by top holders
HolderShares% Held
Asset Management One Co., Ltd.as of 15 Oct 2024443.00k6.11%
Ichiyoshi Asset Management Co., Ltd.as of 21 Aug 202398.80k1.36%
Meiji Yasuda Asset Management Co. Ltd.as of 14 Aug 202395.40k1.32%
Nikko Asset Management Co., Ltd.as of 18 Jul 202366.00k0.91%
SBI Asset Management Co., Ltd.as of 22 Jun 202337.60k0.52%
Nomura Asset Management Co., Ltd.as of 31 Oct 202232.60k0.45%
Simplex Asset Management Co., Ltd.as of 03 Oct 20248.70k0.12%
SEB Investment Management ABas of 28 Feb 20224.20k0.06%
Asset Management One International Ltd.as of 15 Feb 20244.00k0.06%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 26 Jan 20231.40k0.02%
More ▼
Data from 05 Dec 2023 - 17 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.